Skip to main content
SpringerLink
Log in

Typhoid vax “deserves careful consideration” in high-incidence areas

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Cook J, Jeuland M, Whittington D, Poulos C, Clemens J, Sur D, Anh DD, Agtini M, Bhutta Z, DOMI Typhoid Economics Study Group.The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries. Vaccine 26: 6305-6316, No. 50, 25 Nov 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Typhoid vax “deserves careful consideration” in high-incidence areas. Pharmacoecon. Outcomes News 570, 7 (2009). https://doi.org/10.2165/00151234-200905700-00020

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905700-00020

Keywords

Search

Navigation